Rosetta Genomics Ltd (ROSGQ)

OTC Markets

Currency in USD

0.0001

0.0000(0.00%)

Delayed Data·06/07

Fair Value

Unlock Value

Day's Range

0.0001

52 wk Range

0.0001

0.0002

ROSGQ Income Statement

Assess the Rosetta Genomics income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the ROSGQ net worth.

Period Ending:

2007

31/12

2008

31/12

2009

31/12

2010

31/12

2011

31/12

2012

31/12

2013

31/12

2014

31/12

2015

31/12

2016

31/12

Total Revenues

aa.aa

0.2

0.41

1.33

2.88

2.04

Total Revenues Growth

aa.aa

+95.15%

+101.49%

+227.65%

+116.65%

-29.08%

Cost Of Revenues

aa.aa

0.26

0.71

1.31

1.54

Gross Profit

aa.aa

-0.06

-0.3

0.02

1.87

0.5

Gross Profit Growth

aa.aa

+74.21%

-433.33%

+105.59%

+10,911.76%

-73.4%

Gross Profit Margin %

aa.aa

-28.36%

-75.06%

1.28%

65.11%

24.42%

Other Operating Expenses, Total

aa.aa

8.21

13.04

14.27

14.97

13.13

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-4.04%	+58.87%	+9.4%	+4.92%	-12.28%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.25	1.74	1.93	2.96	3.16
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	6.96	11.3	12.34	12.02	9.98
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-8.27

-13.35

-14.25

-13.1

-12.64

Operating Income Growth

aa.aa

+5.81%

-61.45%

-6.78%

+8.09%

+3.54%

EBIT Margin %

aa.aa

-4,112.94%

-3,295.56%

-1,074%

-455.62%

-619.67%

Net Interest Expenses

aa.aa

-1.8

0.13

0.07

-0.54

-0.59

Net Interest Expenses Growth

aa.aa

-18,060%

+107.29%

-45.04%

-852.78%

-7.93%

Interest Expense, Total

aa.aa

-1.84

-0.02

-0.04

-0.59

-0.6

Interest And Investment Income

aa.aa

0.04

0.15

0.11

0.05

0.01

Other Non Operating Expenses, Total

aa.aa

-0.63

0.05

-0.33

-1.04

EBT, Excl. Unusual Items

aa.aa

-10.7

-13.17

-14.51

-14.68

-13.22

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

-10.7

-13.17

-14.51

-14.53

-13.22

EBT, Incl. Unusual Items Growth

aa.aa

-44.81%

-23.13%

-10.18%

-0.12%

+9.02%

EBT, Incl. Unusual Items Margin

aa.aa

-5,321.39%

-3,251.85%

-1,093.52%

-505.32%

-648.26%

Income Tax Expense

aa.aa

0.02

-0.03

Net Income to Company

aa.aa

-10.46

-12.9

-14.53

-17.35

-16.23

Minority Interest

aa.aa

Net Income

aa.aa

-10.46

-12.9

-14.53

-17.35

-16.23

Net Income Growth

aa.aa

-18.43%

-23.33%

-12.63%

-19.41%

+6.41%

Net Income Margin %

aa.aa

-5,202.49%

-3,184.44%

-1,094.65%

-603.3%

-796.13%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-10.7

-13.17

-14.53

-14.55

-13.18

Basic EPS - Continuing Operations

aa.aa

-28.85

-16.47

-15.51

-11.57

-7.15

Basic EPS - Continuing Operations Growth

aa.aa

+83.47%

+42.91%

+5.86%

+25.42%

+38.14%

Diluted EPS - Continuing Operations

aa.aa

-28.85

-16.47

-15.51

-11.57

-7.15

Diluted EPS - Continuing Operations Growth

aa.aa

+83.47%

+42.91%

+5.86%

+25.42%

+38.14%

Basic Weighted Average Shares Outstanding

aa.aa

0.37

0.8

0.94

1.26

1.84

Diluted Weighted Average Shares Outstanding

aa.aa

0.37

0.8

0.94

1.26

1.84

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-7.99

-13.05

-13.95

-12.8

-12.37

EBITDA Growth

aa.aa

+3.96%

-63.26%

-6.93%

+8.27%

+3.39%

EBITDA Margin %

aa.aa

-3,976.62%

-3,221.98%

-1,051.47%

-445.18%

-606.42%

EBIT

aa.aa

-8.27

-13.35

-14.25

-13.1

-12.64

* In Millions of USD (except for per share items)

FAQ

What was Rosetta Genomics’s revenue at year end?

At the end of the last reported fiscal year, Rosetta Genomics (ROSGQ) recorded total revenue of 2.0390 million USD.

How much revenue did Rosetta Genomics report in the most recent quarter?

In its most recent quarterly earnings report, Rosetta Genomics posted revenue of 0.8700 million USD.

What was Rosetta Genomics’s net income for the year?

For the full year, Rosetta Genomics reported net income of -16.2330 million USD.

How much net income did Rosetta Genomics post in the last quarter?

In the most recent quarter, Rosetta Genomics (ROSGQ) posted net income of -2.0710 million USD.

What was Rosetta Genomics’s gross profit for the year?

Gross profit for the year was reported at 0.4980 million USD.

How much gross profit did Rosetta Genomics generate last quarter?

Rosetta Genomics recorded gross profit of 0.3010 million USD in its latest quarterly report.

What was Rosetta Genomics’s annual operating income?

For the full year, Rosetta Genomics (ROSGQ) reported operating income of -12.6350 million USD.

What was Rosetta Genomics’s operating income last quarter?

Quarterly operating income was -1.3710 million USD.

What was Rosetta Genomics’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -1.3125 million USD.

What was the quarter-over-quarter change in EBITDA for Rosetta Genomics?

EBITDA changed by 40.4897% million USD compared to the last quarter.

What is Rosetta Genomics’s most recent gross profit margin?

The latest reported gross profit margin for Rosetta Genomics (ROSGQ) is 34.5977% million USD.

What is Rosetta Genomics’s most recent net income margin?

Net income margin based on recent financials is -238.0459% million USD.

What is Rosetta Genomics’s most recent EBIT margin?

Rosetta Genomics reported an EBIT margin of -157.5862% million USD based on current figures.

How did Rosetta Genomics’s revenue change compared to the previous quarter?

Revenue changed by 8.2090% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Rosetta Genomics?

In the latest quarter, gross profit changed by 18.2711% million USD from the previous quarter.

S&P/TSX

36,729.54

+67.40

+0.18%

S&P/TSX 60

2,166.77

+10.14

+0.47%

US 30

53,821.20

+51.0

+0.09%

US 500

7,799.60

+51.1

+0.66%

S&P 500 VIX

14.65

+0.10

+0.69%

DAX

26,292.00

-39.07

-0.15%

Dollar Index

99.865

-0.034

-0.03%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	71.45	-0.40%	5.64M
Toronto Dominion Bank	171.66	-0.19%	1.43M
Shopify Inc	220.59	+5.15%	1.10M
RBC	299.30	+0.58%	736.70K
Bank of Montreal	256.40	+0.21%	724.94K
Celestica Inc.	486.22	+2.90%	334.44K
Agnico Eagle Mines	250.38	-2.89%	603.85K

Name	Last	Chg. %	Vol.
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Digicann Ventures	0.010	+100.00%	2.00K
ePlay Digital	0.010	+100.00%	7.00K
1933 Industries	0.0100	+100.00%	10.00K
Jaeger Resources	0.01	+100.00%	3.30K
DEFSEC Tech	3.39	+93.71%	79.44K
LFNT Resources	0.20	+90.48%	17.50K

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.05	-68.75%	18.17K
Metaguestai	0.01	-66.67%	1.78K
ImagineAR	0.005	-50.00%	372.99K
Albert Labs International	0.005	-50.00%	1.00K
James Bay Resources Ltd	0.010	-50.00%	1.00K
Psyched Wellness	0.01	-50.00%	3.00K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
Air Canada	30.19	-1.37%	2.91M
Celestica Inc.	486.22	+2.90%	334.44K
Keel Infra	4.64	-6.45%	3.59M
Hut 8	117.300	-7.44%	547.11K
Aurora Cannabis	5.300	+0.19%	979.53K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaa	2.930	+57.60%	4.618
A Aaaaaaaa	3,171.53	+55.65%	4,936.49
Aa Aaaaaaa	24.42	+53.77%	37.55
Aa Aaa Aaaa	127.36	+53.13%	195.03
Aaaaaa Aaa	5.28	+49.79%	7.91
Aaaaaa	34.84	+47.65%	51.44
Aaaa Aaa A	103.89	+43.85%	149.45

Name	Last	Upside	Fair Value
Aaaaaaaaaaa	2.930	+57.60%	4.618
A Aaaaaaaa	3,171.53	+55.65%	4,936.49
Aa Aaaaaaa	24.42	+53.77%	37.55
Aa Aaa Aaaa	127.36	+53.13%	195.03
Aaaaaa Aaa	5.28	+49.79%	7.91
Aaaaaa	34.84	+47.65%	51.44
Aaaa Aaa A	103.89	+43.85%	149.45

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Rosetta Genomics Ltd (ROSGQ)

ROSGQ Income Statement

FAQ

What was Rosetta Genomics’s revenue at year end?

How much revenue did Rosetta Genomics report in the most recent quarter?

What was Rosetta Genomics’s net income for the year?

How much net income did Rosetta Genomics post in the last quarter?

What was Rosetta Genomics’s gross profit for the year?

How much gross profit did Rosetta Genomics generate last quarter?

What was Rosetta Genomics’s annual operating income?

What was Rosetta Genomics’s operating income last quarter?

What was Rosetta Genomics’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Rosetta Genomics?

What is Rosetta Genomics’s most recent gross profit margin?

What is Rosetta Genomics’s most recent net income margin?

What is Rosetta Genomics’s most recent EBIT margin?

How did Rosetta Genomics’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Rosetta Genomics?

Trending Stocks